Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.21
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
1.65
Today|||52-Week Range
19.80
+84.48%
Year-to-Date
Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU
Jan 11 / Zacks.com - Paid Partner Content
Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
Jan 09 / Zacks.com - Paid Partner Content
Orexigen Therapeutics (OREX) Shares March Higher, Can It Continue?
Jan 10 / Zacks.com - Paid Partner Content
The Medicines Co LDL-Lowering Drug Positive in Phase II
Jan 09 / Zacks.com - Paid Partner Content
Celgene Issues Preliminary 2016 Results, Lifts 2017 View
Jan 10 / Zacks.com - Paid Partner Content